Capitalize on the AI infrastructure supercycle with our selection of the 46 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
To own Insperity, you need to be comfortable with a people-intensive HR outsourcer that is currently unprofitable but still returning cash via dividends. The confirmed US$0.6000 quarterly payout and recent insider buying do not materially change the near term picture, where the key catalyst remains execution on HRScale with Workday, and the biggest risk is that healthcare and benefits costs continue to pressure already thin margins.
The most relevant recent announcement here is management’s Q2 and full year 2026 guidance, which brackets net income between a small loss and modest profit. That wide range underlines how sensitive earnings are to healthcare cost trends and worksite employee growth, even as Insperity keeps its dividend flat at US$0.60 per share. Taken together with insider purchases, it frames a story where cash returns and operating volatility are sitting side by side.
Yet beneath the consistent dividend, investors should be aware of how quickly rising healthcare and pharmacy costs could...
Read the full narrative on Insperity (it's free!)
Insperity's narrative projects $8.0 billion revenue and $94.5 million earnings by 2029. This requires 5.4% yearly revenue growth and a $101.5 million earnings increase from -$7.0 million today.
Uncover how Insperity's forecasts yield a $40.50 fair value, a 26% upside to its current price.
While consensus focuses on cost pressure and a tight 2026 outlook, the most optimistic analysts were penciling in about US$7.7 billion of revenue and US$113.9 million of earnings by 2029, so this dividend news could eventually tilt views on whether that much brighter path still looks realistic or needs to be revisited.
Explore 4 other fair value estimates on Insperity - why the stock might be worth over 6x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English